How to Spend Your Oracle Budget: Practical Guidance for Protein Structure Prediction Models
A benchmark compares oracle budget-aware guidance methods for protein structure prediction models, including FK-steering, DPO, Best K-of-N sampling, and Optimisation Over Outputs (O3). Evaluation on calmodulin (1CLL) and E. coli aspartate transcarbamoylase (9EEH) shows no single method dominates across all budgets and oracles. O3 is most effective at low oracle budgets, while FK-steering and DPO improve as budget increases.
Foundation models for protein structure prediction remain unreliable on certain targets. External oracles can flag and correct failures, but biological oracles are expensive, making oracle budget a critical constraint. Existing guidance methods differ in how they spend this budget, yet no systematic comparison existed. This work benchmarks FK-steering, DPO, Best K-of-N sampling, and O3, extending O3 to protein structure prediction. Evaluation on two protein targets reveals that no single method consistently dominates; O3 is most effective at low budgets, while FK-steering and DPO perform better as budget increases. The findings provide actionable recommendations for practitioners under real-world oracle constraints.
O3 applies off-the-shelf optimisers within a generative model's latent subspace, enabling efficient use of limited oracle queries. The benchmark indicates that method selection should depend on available oracle budget: O3 for low budgets, FK-steering and DPO for higher budgets. This suggests a trade-off between latent-space optimization and fine-tuning approaches based on oracle cost.
For practitioners in computational biology and drug discovery, oracle budget is a practical constraint. The lack of a universally dominant method implies that teams must evaluate guidance strategies against their specific budget and target proteins. The extension of O3 to protein structure prediction may lower costs for early-stage screening.
Reducing oracle spending can lower the cost of protein structure prediction workflows, making them more accessible for biotech and pharmaceutical research. The actionable recommendations may improve ROI for teams using foundation models in structural biology.
Next signals include adoption of O3 in protein design pipelines, further benchmarks on diverse protein families, and development of hybrid methods that adaptively switch strategies based on budget. Watch for integration into commercial protein structure prediction platforms.